I’ve reviewed some earlier articles a few years back that are very relevant to scientists studying the origin of SARS and Vaccines that contain military patented Mycoplasmas, that caused Cancer, Lyme Disease and Aids in the past.
Dr. Garth Nicolson gave a brilliant lecture on – Weaponized Mycoplasmas-Cancer, AIDS, Weaponized Mycoplasmas & Gulf War Illness due to Multiple Vaccinations on Gulf War Soldiers who suffered long term illnesses after service called Gulf War Syndrome.
Prof. Garth Nicolson’s hypothesis is straightforward:
“The emergence of new illnesses and an increase in the incidence rate of previously described signs & symptoms are due to our toxic environment & the purposeful development & testing of Weapons of Mass Destruction.“
Dr. Nicolson heads the Institute for Molecular Medicine. He spoke at the 9th Common Cause Medical Research Foundation Conference, Sudbury, Ontario, Canada on Aug. 29-31, 2008.
All these Mycoplasmas were used on Iraq but also on the US population.
Lyme, HPV, Chlamydia, H1N1, SARS, all have the same military patented Mycoplasma family in common, these have been released on humanity for decades and used in the Middle Eastern conflicts and are also used in geoengineering over 45+ years.
These are in the patent archives, here a Patent of mycoplasma hypo-pneumoniae which sounds like COVID-19
Mycoplasma has been sprayed in various operations over different demographic populations to cause diseases and prime people for new ones, it is one of the disease agents in AIDS, Multiple Sclerosis, Wegener’s disease, Rheumatoid Arthritis, Type I diabetes, Hepatitis, Pancreatitis, Arthritis, Heart disease, Anemia; And neurologic disease such as Parkinson’s disease, Crohn’s colitis, Alzheimer’s, Creutzfeldt-Jakob disease and other autoimmune and neurological illnesses. More on the increased pilot spraying projects on Mycoplasma here
Professor Donald Scott is a veteran of WWII. He has extensively researched neurosystemic degenerative diseases and written many papers on the relationship between degenerative diseases and Mycoplasma fermentans. His research is based upon solid government evidence.
”My conclusions are entirely based upon official documents: 80% are United States or Canadian official government documents, and 20% are articles from peer-reviewed journals, such as the Journal of the American Medical Association, The New England Journal of Medicine, and The Canadian Medical Association Journal. The journal articles and government documents complement each other. We also have a document from Dr. Shyh-Ching Lo which names the mycoplasma as a cause of cancer”. – Professor Donald Scott.
Dr. Charles Engel who is with the National Institutes of Health, Bethesda, Maryland, stated at an NIH meeting on February 7, 2000, “I am now of the view that the probable cause of Chronic Fatigue Syndrome and fibromyalgia is the mycoplasma”.
Mycoplasmal pneumonia is connected to H1N1, bird flu and Swine mycoplasmal pneumonia.
It also encourages environments for fungus and there is a medicinal research group that classes cancer as a fungus. Medical research shows that cancer arises through damaged DNA which is interesting when considering that Mycoplasma contains incomplete DNA and when the bacteria infect the host they can copy the host DNA and this causes Cancer to arise.
Testimonial evidence that the biotech and bio pharmaceutical stakeholders, investors and CEOs of these industries have their two-sided philanthropic theatricals with government backed financing; While governments are spraying Mycoplasma bacteria blended with geoengineering aerosols to prime wildlife, insect pollinators, crops, people and agricultural animals for more diseases; The Hegelian dialectic is so they can rake in the profits from these illnesses and disease exponentially on the rise for the manufacture of pills and vaccines that they then create as a result and which are also laced with more mycoplasma and toxins.
Related articles and books
Dr Garth Nicolson’s references
Murray-Leisure, K., Daniels, M.O., Sees, J., Suguitan, E., Zangwill, B., Bagheri, S., Brinser, E., Kimber, R., Kurban, R. Greene, W.H. Mucocutaneous-Intestinal-Rheumatic Desert Syndrome (MIRDS). Definition, histopathology, incubation period, clinical course and association with desert sand exposure. Intern. J. Med. 1997; 1: 47-72.
2 Nicolson, G.L. and Nicolson, N.L. Chronic Fatigue Illness and Operation Desert Storm. J. Occup. Environ. Med. 1996; 38: 14-16.
3 Nicolson, G.L., Nasralla, M, Hier, J. and Nicolson, N.L. Gulf War Illnesses: role of chemical, radiological and biological exposures. In: War and Health, H. Tapanainen, ed., Helinsiki, in press, 1998.
4 Nicolson, G.L., Hyman, E., Korényi-Both, A., Lopez, D.A, Nicolson, N.L., Rea, W., Urnovitz, H. Progress on Persian Gulf War Illnesses: reality and hypotheses. Intern. J. Occup. Med. Tox. 1995; 4: 365-370.
5 U. S. Congress, Senate Committee on Banking, Housing and Urban Affairs, U. S. chemical and biological warfare-related dual use exports to Iraq and their possible impact on the health consequences of the Persian Gulf War , 103rd Congress, 2nd Session, Report May 25, 1994.
6 Nicolson, G.L. Chronic infections as a common etiology for many patients with Chronic Fatigue Syndrome, Fibromyalgia Syndrome and Gulf War Illnesses. Intern. J. Med. 1998; 1: 42-46.
7 NIH Technology Assessment Workshop Panel. The Persian Gulf Experience and Health. J. Amer. Med. Assoc. (JAMA) 1994; 272: 391-396.
8 U. S. Congress, House Committee on Government Reform and Oversight, Gulf War veterans : DOD continue to resist strong evidence linking toxic causes to chronic health effects, 105th Congress, 1st Session, Report 105-388, 1997.
9 Nicolson, G.L. and Nicolson, N.L. Diagnosis and treatment of mycoplasmal infections in Gulf War Illness-CFIDS patients. Intern. J. Occup. Med. Immunol. Tox. 1996; 5: 69-78.
10 Nicolson, G.L., Nicolson, N.L. and Nasralla, M. Mycoplasmal infections and Chronic Fatigue Illness (Gulf War Illness) associated with deployment to Operation Desert Storm. Intern. J. Med. 1997; 1: 80-
11 Nicolson, G.L., Nasralla, M, Hier, J. and Nicolson, N.L. Diagnosis and treatment of chronic mycoplasmal infections in Fibromyalgia Syndrome and Chronic Fatigue Syndrome: relationship to Gulf War Illness. Biomed. Therapy 1998; 16: 266-271.
12 U. S. General Accounting Office, Gulf War Illnesses: improved monitoring of clinical progress and reexamination of research emphasis are needed. Report GAO/SNIAD-97-163, 1997.
13 Baseman, J.B. and Tully, J.G. Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety. Emerg. Infect. Diseases 1997; 3: 21-32.
14 Cassell, G.H. and Cole, B.C. Mycoplasmas as agents of human disease. New Eng. J. Med. 1981; 304: 80-89.
15 Choppa, P.C., Vojdani, A., Tagle, C., Andrin, R. and Magtoto, L. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with Chronic Fatigue Syndrome. Mol. Cell Probes 1998; 12: 301-308.
16 Hier, J., Nasralla, M. and Nicolson, G.L. Detection of mycoplasmal infections in blood of patients with rheumatoid arthritis. Brit. J. Rheumatol. 1998; in press.
17 Lo, S.-C., Dawson, M.S., Newton, P.B., Sonoda, A.A., Shih, W.-K., Engler, W.F., Wang, R.Y.-H. and Wear, D.J. Association of the virus-like infectious agent originally reported in patients with AIDS with acute fatal disease in previously healthy non-AIDS patients. Amer. J. Trop. Med. Hyg. 1989; 41: 364-376.
18 Lo, S.-C., Wear, D.J., Shih, W.-K., Wang, R.Y.-H., Newton, P.B. and Rodriguez, J.F. Fatal systemic infections of nonhuman primates by Mycoplasma fermentans (incognitus strain). Clin. Infect. Diseases 1993; 17(Suppl 1): S283-S288.
19 Lo, S.-C., Buchholz, C.L., Wear, D.J., Hohm, R.C. and Marty, A.M. Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systemically infected by Mycoplasma fermentans (incognitus strain). Mod. Pathol. 1991; 6: 750-754.
20 Nicolson, G.L. and Nicolson, N.L. Doxycycline treatment and Desert Storm. J. Amer. Med. Assoc. (JAMA) 1995; 273: 618-619.
21 Nicolson, G.L. and Nicolson, N.L. Mycoplasmal infections–Diagnosis and treatment of Gulf War Syndrome/CFIDS. CFIDS Chronicle 1996; 9(3): 66-69.
22 Nicolson, G.L. Considerations when undergoing treatment for chronic infections found in Chronic Fatigue Syndrome, Fibromyalgia Syndrome and Gulf War Illnesses. (Part 1). Antibiotics Recommended when indicated for treatment of Gulf War Illness/CFIDS/FMS (Part 2). Intern. J. Med. 1998; 1: 115-117, 123-128.
23 Nicolson, G.L. and Nicolson, N.L. Gulf War Illnesses: complex medical, scientific and political paradox. Medicine Conflict & Survival 1998; 14: 156-165.
24 Nicolson, G.L. and Nicolson, N.L. The eight myths of Operation Desert Storm and Gulf War Syndrome. Medicine Conflict & Survival 1997; 13: 140-146.